Follow the KERYX BIOPHARMACEUTICALS INC stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). The latest transaction was reported on 10 February 2016 (Cession). Among the most active insiders: Adams Brian. The full history is openly available.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
6 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Keryx Biopharmaceuticals Inc es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades renales. Cotiza en NASDAQ bajo el ticker KERX.